deferoxamine has been researched along with epigallocatechin gallate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, AK; Baerson, SR; Ferreira, D; Hodges, TW; Kim, YP; Li, XC; Nagle, DG; Zhou, YD | 1 |
| Higuchi, A; Koreeda, A; Tsunenari, S; Yonemitsu, K | 1 |
| Amit, T; Avramovich-Tirosh, Y; Mandel, S; Reznichenko, L; Weinreb, O; Youdim, MB; Zheng, H | 1 |
| Brooks, TC; Chen, A; Fu, Y; Lowery-Nordberg, M; Manuszak, RP; Sequeira, AP; Shackelford, RE; Wang, S | 1 |
4 other study(ies) available for deferoxamine and epigallocatechin gallate
| Article | Year |
|---|---|
Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts.
Topics: Catechin; Cell Hypoxia; DNA-Binding Proteins; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Molecular Structure; Nuclear Proteins; Stereoisomerism; Structure-Activity Relationship; Tea; Transcription Factors; Vascular Endothelial Growth Factor A | 2004 |
Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation--a mechanism of protective effects of EGCg against paraquat toxicity.
Topics: Animals; Antioxidants; Catechin; Cyclic N-Oxides; Deferoxamine; Drug Interactions; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Herbicides; Iron Chelating Agents; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Microsomes, Liver; Paraquat; Rats; Rats, Wistar; Spin Trapping; Superoxides; Tea | 2003 |
Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antigens, CD; Blotting, Western; Catechin; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Deferoxamine; Dose-Response Relationship, Drug; Drug Interactions; Electrophoresis, Gel, Two-Dimensional; Gene Expression; Humans; Immunoprecipitation; Iron; Iron Chelating Agents; Neuroblastoma; Neuroprotective Agents; Receptors, Transferrin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2006 |
Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells.
Topics: Antibodies; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Catechin; Cell Culture Techniques; Cell Cycle Proteins; Cell Line; Chromosome Breakage; Deferoxamine; DNA-Binding Proteins; Drug Synergism; Humans; Iron; Iron Chelating Agents; Mutagens; Organometallic Compounds; Protein Serine-Threonine Kinases; Receptors, Transferrin; Recombinant Fusion Proteins; Salicylates; tert-Butylhydroperoxide; Thioctic Acid; Tumor Suppressor Proteins | 2006 |